Pruritus (itching) can be associated with cancer, but it is rarely the sole early indicator and most commonly occurs in advanced stages. Certain cancers show stronger links to pruritus than others: lymphomas (particularly Hodgkin's lymphoma), leukemias, and ovarian cancer are the most frequently associated malignancies. The itching may be localized to tumors or generalized across the body, and is sometimes called "paraneoplastic pruritus" when it results from the cancer's systemic effects rather than direct skin involvement. The mechanism involves inflammatory mediators, hormonal changes, or immune system responses triggered by the cancer. However, pruritus is extremely common and has many benign causes—dry skin, allergies, dermatitis, liver disease, kidney disease, hyperthyroidism, and numerous medications are far more typical culprits. A person experiencing persistent, unexplained itching should consult a healthcare provider for evaluation, but the presence of itching alone is not a reliable indicator of cancer. Cancer diagnosis requires imaging, blood work, biopsies, or other clinical findings alongside any skin symptoms. Pruritus becomes medically significant in cancer contexts mainly when it accompanies other concerning symptoms or occurs in patients already diagnosed with or at high risk for malignancy.